Al's Comment:
Our next webinar will be on GammaTile, on Monday Oct 30, 2023 at 7pm eastern Eastern.
GammaTile is an FDA approved treatment for brain tumors. It is implanted at the time of a surgery and releases radiation to the tumor bed. The speaker will tell us the most current data on outcomes.
Posted on: 10/18/2023
Our next webinar will be on Monday Oct 30, 2023 at 7pm eastern Eastern:<br>
Topic: GammaTile - Clinical Data and Patient Story<br>
Speaker: Ken Tatebe, MD, PhD, Radiation oncologist, RUSH University Medical Center<br>
Description: GammaTile is a Surgically Targeted Radiation Therapy (STaRT) for operable brain tumors that provides immediate radiation treatment after tumor removal. Dr. Tatebe will present recent GammaTile clinical data and findings, and there will be a brief patient story.
<br><br>No registration required. Just go to
https://virtualtrials.org/webinar a few minutes before the event!
Click HERE to return to brain tumor news headlines.
